Alpha 2.0
Login Register
» Articles » PMID: 36969044

Editorial: CRISPR Advancement in Cancer Research and Future Perspectives

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Mar 27
PMID 36969044
Authors
Alessio Biagioni
Reza Mohammadinejad
Affiliations
Soon will be listed here.
Citing Articles

Bridging the gap between omics research and dental practice.

Kabbashi S, Roomaney I, Chetty M BDJ Open. 2024; 10(1):16.

PMID: 38438363 PMC: 10912736. DOI: 10.1038/s41405-024-00199-3.

References
1.
Mohammadinejad R, Biagioni A, Arunkumar G, Shapiro R, Chang K, Sedeeq M . EMT signaling: potential contribution of CRISPR/Cas gene editing. Cell Mol Life Sci. 2020; 77(14):2701-2722. PMC: 11104910. DOI: 10.1007/s00018-020-03449-3. View
2.
Haslauer T, Greil R, Zaborsky N, Geisberger R . CAR T-Cell Therapy in Hematological Malignancies. Int J Mol Sci. 2021; 22(16). PMC: 8396650. DOI: 10.3390/ijms22168996. View
3.
Dehshahri A, Biagioni A, Bayat H, Lee E, Hashemabadi M, Fekri H . Editing Genes by CRISPR-Cas: Current Insights and Future Perspectives. Int J Mol Sci. 2021; 22(21). PMC: 8583549. DOI: 10.3390/ijms222111321. View
4.
Cyranoski D . CRISPR gene-editing tested in a person for the first time. Nature. 2016; 539(7630):479. DOI: 10.1038/nature.2016.20988. View
5.
Katti A, Diaz B, Caragine C, Sanjana N, Dow L . CRISPR in cancer biology and therapy. Nat Rev Cancer. 2022; 22(5):259-279. DOI: 10.1038/s41568-022-00441-w. View